Home
About
Overview
Sharing Data
ORCID
Help
History (18)
Involvement of FKHR-dependent TRADD expression in chemotherapeutic drug-induced apoptosis.
Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN.
Real-time effects of centrotemporal spikes on cognition in rolandic epilepsy: An EEG-fMRI study.
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019 06 13; 380(24):2295-2306.
View in:
PubMed
subject areas
Aged
Canagliflozin
Cardiovascular Diseases
Creatinine
Diabetes Mellitus, Type 2
Diabetic Nephropathies
Double-Blind Method
Female
Follow-Up Studies
Glomerular Filtration Rate
Humans
Kidney Failure, Chronic
Male
Middle Aged